¼¼°èÀÇ °ñ ÅëÁõ Ä¡·á ½ÃÀå º¸°í¼­(2025³â)
Bone Pain Treatment Global Market Report 2025
»óǰÄÚµå : 1764266
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,272,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,065,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,859,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

°ñ ÅëÁõ Ä¡·á ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â°£ °­·ÂÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. 2029³â¿¡´Â CAGR 7.3%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 80¾ï 1,000¸¸ ´Þ·¯·Î ¼ºÀåÀÌ ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº °ñ ÅëÁõÀÇ Ç¥Àû »ý¹°ÇÐÀû ¿ä¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ºñħ½ÀÀû Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ±âÈ£ Áõ°¡, °ñ ÅëÁõ °ü¸®¿¡¼­ °³º°È­ ÀÇ·áÀÇ Ã¤¿ë È®´ë, ½ÃÆÇ ÁøÅëÁ¦ÀÇ ¼ö¿ä È®´ë, ½ÅÈï ½ÃÀå¿¡¼­ ÇコÄɾÀÇ ¾×¼¼½º °³¼± µî¿¡ ±âÀÎÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ ±â°£¿¡ ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â °ñ ÅëÁõ °ü¸®¿¡¼­ÀÇ ÀΰøÁö´É ÅëÇÕ, ÅëÁõ ¿ÏÈ­¸¦ À§ÇÑ °¡»óÇö½Ç ÀÌ¿ë, °ñ´Ù°øÁõ¼º °ñ ÅëÁõ Ä¡·á¿¡¼­ÀÇ Áøº¸, ±â¼ú °­È­Çü ÅëÁõ ¿ÏÈ­ ÀåÄ¡ °³¹ß, Å©·Î½ºÅ×¶óÇÇ ÅëÇÕ, ¿Ü°úÀû °³ÀÔ¿¡¼­ÀÇ ·Îº¿°øÇÐ µµÀÔ µîÀÌ ÀÖ½À´Ï´Ù.

°ñ´Ù°øÁõÀÇ À¯º´·ü Áõ°¡´Â ÇâÈÄ °ñ ÅëÁõ Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °ñ´Ù°øÁõÀº °ñ¹Ðµµ³ª °­µµ°¡ ÀúÇÏµÇ¾î »À°¡ ¾àÇØÁö°í ½±°Ô °ñÀýµÇ´Â ÁúȯÀÔ´Ï´Ù. °ñ¹Ðµµ´Â ÀϹÝÀûÀ¸·Î ³ªÀ̰¡ µé¸é¼­ ÀúÇϵDZ⠶§¹®¿¡, ÀÌ ÁúȯÀº ÁÖ·Î ¼¼°è Àα¸ÀÇ °í·ÉÈ­¿¡ ÀÇÇØ ÀϹÝÀûÀ¸·Î µÇ°í ÀÖ½À´Ï´Ù. °ñ ÅëÁõ Ä¡·á´Â °ñ´Ù°øÁõ¿¡ µû¸¥ ºÒÄè°¨À» ¿ÏÈ­ÇÏ°í ¿îµ¿ ´É·ÂÀ» Çâ»ó½ÃŰ¸ç »îÀÇ Áú Çâ»óÀ» Áö¿øÇÔÀ¸·Î½á °ñ´Ù°øÁõÀÇ ÅëÁõ °ü¸®¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 6¿ù È£ÁÖ º¸°Çº¹Áö·¦Àº 2022³â¿¡´Â È£ÁÖ¿¡¼­ ¾à 85¸¸ 3,600¸íÀÌ °ñ´Ù°øÁõ ¶Ç´Â °ñ°¨¼ÒÁõ¿¡ ÀÌȯµÆÀ¸¸ç °°Àº ÇØ »ç¸ÁÀÚ ¼ö´Â 2,659¸íÀ̾ú´Ù°í º¸°íÇß½À´Ï´Ù. µû¶ó¼­ °ñ´Ù°øÁõÀÇ À¯º´·ü »ó½ÂÀº È¿°úÀûÀÎ °ñÅë Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä¸¦ Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

°ñ ÅëÁõ Ä¡·á ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³ÇÏ´Â ÁÖ¿ä ±â¾÷Àº ó¹æÀüÀÌ ÀÖ´Â ¿þ¾î·¯ºí ±â±â µî Ç¥ÀûÀ» Á¼Èù ÅëÁõ ¿ÏÈ­¸¦ ½ÇÇöÇÏ´Â Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀÇ °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÇ·á ½ÂÀÎ ÀåÄ¡´Â ½Åü¿¡ ÀåÂøÇϰí Àü±â ÀÚ±Ø ¹× Áøµ¿°ú °°Àº Ä¡·á¹ýÀ» Á¦°øÇÏ¿© Ç÷¾× ¼øÈ¯À» ÃËÁøÇÏ°í ¿°ÁõÀ» ¾ïÁ¦Çϸç ÅëÁõ ½ÅÈ£¸¦ Â÷´ÜÇÏ¿© °ñ ÅëÁõÀ» ¿ÏÈ­ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2025³â 5¿ù ¹Ì±¹ ÀÇ·á±â±â Á¦Á¶¾÷üÀÎ ¿À½ºÅ׿À ºÎ½ºÆ® Çコ´Â °ñ¹Ðµµ°¡ ³·Àº »ç¶÷µéÀ» À§ÇØ Æ¯º°È÷ ¼³°èµÈ ÃÖÃÊÀÇ FDA ½ÂÀÎ ¿þ¾î·¯ºí ÀåºñÀÎ ¿À½ºÅ׿À ºÎ½ºÆ®¸¦ Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ¿þ¾î·¯ºí º§Æ®´Â ÀúÁøÆøÀÇ °íÁÖÆÄ Áøµ¿ ¿ä¹ý(20-40Hz)À» ôÃß¿Í ¾ûµ¢ÀÌ¿¡ ÁÖ°í, °ñ°¨¼ÒÁõ Æó°æ ÈÄ ¿©¼ºÀÇ °ñ¹Ðµµ¿Í °­µµ ÀúÇϸ¦ ´ÊÃß´Â °ÍÀ» ¸ñÀûÀ¸·Î ÇÕ´Ï´Ù. Á¤»óÀûÀΠȰµ¿ Áß¿¡ ¸ÅÀÏ 30ºÐ µ¿¾È »ç¿ëÇÒ ¼ö ÀÖµµ·Ï ¼³°èµÇ¾úÀ¸¸ç, Osteoboost´Â ½É°¢ÇÑ ºÎÀÛ¿ë ¾øÀÌ °ñ °Ç°­À» À¯ÁöÇÏ´Â ÀÓ»óÀû È¿°ú¸¦ ÀÔÁõÇÕ´Ï´Ù. ¿À½ºÅ׿À ºÎ½ºÆ®´Â Àüµ¿ Áøµ¿ ÆÑ, ¾Ð·Â ¼¾¼­, °¡¼Óµµ°è¸¦ ³»ÀåÇϰí Á¤È®ÇÏ°í ¾ÈÀüÇÑ Ä¡·á¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ ¹× Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï ¹× °ü¼¼, Äڷγª ¹× ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼® ¹× Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº° ¹× ±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ ¹× ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å· ¹× ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹® ¹× Àü·«

Á¦36Àå ºÎ·Ï

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Bone pain treatment involves medical interventions aimed at relieving discomfort or aching in the bones, which may result from conditions such as fractures, infections, cancer, or chronic illnesses. These treatments typically encompass medications, physical therapy, and, in some cases, surgical procedures to target the root cause and mitigate pain.

The primary categories of bone pain treatment include pharmacological treatments, non-pharmacological approaches, and surgical interventions. Pharmacological treatments involve the use of drugs to prevent, manage, or treat medical conditions by influencing specific biological functions. The drug classes commonly employed include analgesics, antidepressants, anticonvulsants, and corticosteroids. Bone pain is generally treated for conditions such as injuries, infections, myalgia, and tumors. Treatment options are distributed via direct sales, retail pharmacies, and online pharmacies, and are used by end users such as hospitals, clinics, and homecare settings.

The bone pain treatment market research report is one of a series of new reports from The Business Research Company that provides bone pain treatment market statistics, including the bone pain treatment industry's global market size, regional shares, competitors with the bone pain treatment market share, detailed bone pain treatment market segments, market trends and opportunities, and any further data you may need to thrive in the bone pain treatment market. This bone pain treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bone pain treatment market size has grown strongly in recent years. It will grow from $5.62 billion in 2024 to $6.05 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth during the historic period can be attributed to the rising prevalence of chronic conditions such as osteoporosis and arthritis, a surge in bone disorder cases, an expanding elderly population, increasing awareness regarding bone health, and a higher incidence of cancer-related bone metastases.

The bone pain treatment market size is expected to see strong growth in the next few years. It will grow to $8.01 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to the increasing demand for targeted biologic therapies for bone pain, rising preference for non-invasive treatment options, the expanding adoption of personalized medicine in bone pain management, growing demand for over-the-counter pain relievers, and improved access to healthcare in emerging markets. Key trends anticipated during this period include the integration of artificial intelligence in bone pain management, the use of virtual reality for pain relief, advancements in treatments for osteoporotic bone pain, the development of technology-enhanced pain relief devices, cross-therapy integration, and the incorporation of robotics in surgical interventions.

The increasing prevalence of osteoporosis is expected to propel the growth of the bone pain treatment market going forward. Osteoporosis is a condition marked by reduced bone density and strength, making bones more fragile and susceptible to fractures. This condition is becoming more common, primarily due to the aging global population, as bone density typically decreases with age. Bone pain treatments play a critical role in managing osteoporosis by relieving associated discomfort, improving mobility, and supporting better quality of life. For instance, in June 2024, the Australian Institute of Health and Welfare reported that approximately 853,600 individuals in Australia were living with osteoporosis or osteopenia in 2022, with the disease contributing to 2,659 deaths that year. Therefore, the rising prevalence of osteoporosis is significantly driving the demand for effective bone pain treatments.

Major companies operating in the bone pain treatment market are focusing on developing innovative solutions, such as prescription wearable devices, to deliver targeted pain relief. These medically approved devices are worn on the body and offer therapies like electrical stimulation or vibration to alleviate bone pain by enhancing circulation, reducing inflammation, or disrupting pain signals. For instance, in May 2025, Osteoboost Health Inc., a US-based medical equipment manufacturer, launched Osteoboost, the first FDA-cleared wearable device specifically designed for individuals with low bone density. This wearable belt delivers low-amplitude, high-frequency vibration therapy (20-40 Hz) to the spine and hips and is intended to slow the loss of bone density and strength in postmenopausal women with osteopenia. Designed for daily 30-minute use during normal activities, Osteoboost has demonstrated clinical efficacy in preserving bone health without significant adverse events. The device integrates a motorized vibration pack, pressure sensor, and accelerometers to ensure precise and safe therapy delivery.

In November 2023, Boston Scientific Corporation, a US-based biotechnology company, acquired Relievant Medsystems Inc. for $850 million. This strategic acquisition was aimed at expanding Boston Scientific's chronic pain management portfolio and reinforcing its leadership in the interventional pain space. By integrating Relievant's innovative, FDA-cleared solutions, the company seeks to enhance patient access to effective treatments and improve clinical outcomes. Relievant Medsystems Inc., also based in the US, specializes in treating chronic low back pain, with a particular focus on vertebrogenic pain, offering targeted therapies that address the underlying source of pain.

Major players in the bone pain treatment market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb Company, Novartis International AG, GSK plc, Medtronic plc, Eli Lilly and Company, Amgen Inc., Stryker Corporation, Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma Inc., Endo International plc, Amneal Pharmaceuticals Inc., Marksans Pharma Limited, and APS Materials Inc.

North America was the largest region in the bone pain treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bone pain treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bone pain treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bone pain treatment market includes revenues earned by entities by providing services such as pharmacological therapy services, physical therapy and rehabilitation services, surgical intervention services, pain management clinics, and diagnostic imaging and evaluation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The bone pain treatment also includes sales of acetaminophen, ibuprofen, naproxen, morphine, oxycodone, alendronate, and prednisone. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bone Pain Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bone pain treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for bone pain treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bone pain treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Bone Pain Treatment Market Characteristics

3. Bone Pain Treatment Market Trends And Strategies

4. Bone Pain Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Bone Pain Treatment Growth Analysis And Strategic Analysis Framework

6. Bone Pain Treatment Market Segmentation

7. Bone Pain Treatment Market Regional And Country Analysis

8. Asia-Pacific Bone Pain Treatment Market

9. China Bone Pain Treatment Market

10. India Bone Pain Treatment Market

11. Japan Bone Pain Treatment Market

12. Australia Bone Pain Treatment Market

13. Indonesia Bone Pain Treatment Market

14. South Korea Bone Pain Treatment Market

15. Western Europe Bone Pain Treatment Market

16. UK Bone Pain Treatment Market

17. Germany Bone Pain Treatment Market

18. France Bone Pain Treatment Market

19. Italy Bone Pain Treatment Market

20. Spain Bone Pain Treatment Market

21. Eastern Europe Bone Pain Treatment Market

22. Russia Bone Pain Treatment Market

23. North America Bone Pain Treatment Market

24. USA Bone Pain Treatment Market

25. Canada Bone Pain Treatment Market

26. South America Bone Pain Treatment Market

27. Brazil Bone Pain Treatment Market

28. Middle East Bone Pain Treatment Market

29. Africa Bone Pain Treatment Market

30. Bone Pain Treatment Market Competitive Landscape And Company Profiles

31. Bone Pain Treatment Market Other Major And Innovative Companies

32. Global Bone Pain Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bone Pain Treatment Market

34. Recent Developments In The Bone Pain Treatment Market

35. Bone Pain Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â